AZN
Astrazeneca Plc
11,794.00
46.00
(0.39%)
The current AZN market cap is 182.79B. The company's latest EPS is 212.2 and P/E is 55.05.
| Year End 31 December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 22.09B | 24.38B | 26.62B | 37.42B | 44.35B |
| Operating Income | 1.4B | 1.59B | 4.08B | -293M | 3.54B |
| Net Income | 2.16B | 1.34B | 3.2B | 112M | 3.29B |
| Year End 31 December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 60.65B | 61.38B | 66.73B | 105.36B | 96.48B |
| Total Liabilities | 46.61B | 46.78B | 51.09B | 66.08B | 59.43B |
| Total Equity | 14.04B | 14.6B | 15.64B | 39.29B | 37.06B |
| Year End 31 December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 2.62B | 2.97B | 4.8B | 5.96B | 9.81B |
| Investing | 963M | -657M | -285M | -11.06B | -2.96B |
| Financing | -2.04B | -1.77B | -2.2B | 3.65B | -6.82B |
| Market Cap | 182.79B |
| Price to Earnings Ratio | 55.05 |
| Price to Sales Ratio | 4.08 |
| Price to Cash Ratio | 29.32 |
| Price to Book Ratio | 4.88 |
| Dividend Yield | 2.03% |
| Shares Outstanding | 1.55B |
| Average Volume (1 week) | 2.27M |
| Average Volume (1 Month) | 1.58M |
| 52 Week Change | 13.4% |
| 52 Week High | 12,390.00 |
| 52 Week Low | 9,399.00 |
| Spread (Intraday) | 4 (0.03%) |
| Company Name | Astrazeneca Plc |
| Address |
1 francis crick avenue cambridge CB2 0AA |
| Website | https://www.astrazeneca.com |
| Industry | pharmaceutical preparations (2834) |